173 related articles for article (PubMed ID: 31342798)
1.
Huang C; Wang L; Song H; Wu C
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3037-3042. PubMed ID: 31342798
[No Abstract] [Full Text] [Related]
2.
Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3278-3285. PubMed ID: 31379206
[No Abstract] [Full Text] [Related]
3. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
4. LncRNA SNHG20 enhances the progression of oral squamous cell carcinoma by regulating the miR-29a/DIXDC1/Wnt regulatory axis.
Chen ZF; Wang Y; Sun LL; Ding SY; Jinag H
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5436-5445. PubMed ID: 32495922
[TBL] [Abstract][Full Text] [Related]
5. Wnt/β-catenin signaling pathway participates in the effect of miR-626 on oral squamous cell carcinoma by targeting RASSF4.
Cui SH; Hu XD; Yan Y
J Oral Pathol Med; 2021 Nov; 50(10):1005-1017. PubMed ID: 34121238
[TBL] [Abstract][Full Text] [Related]
6. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
[TBL] [Abstract][Full Text] [Related]
7. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2.
Wang X; Zhang Y; Zhang S; Duan L
Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/β-catenin signaling pathway.
Wang Z; Guan W; Ma Y; Zhou X; Song G; Wei J; Wang C
BMC Cancer; 2023 Jul; 23(1):668. PubMed ID: 37460940
[TBL] [Abstract][Full Text] [Related]
9. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
Yang K; Zhao J; Liu S; Man S
Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-29a upregulates MMP2 in oral squamous cell carcinoma to promote cancer invasion and anti-apoptosis.
Lu L; Xue X; Lan J; Gao Y; Xiong Z; Zhang H; Jiang W; Song W; Zhi Q
Biomed Pharmacother; 2014 Feb; 68(1):13-9. PubMed ID: 24210072
[TBL] [Abstract][Full Text] [Related]
11. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
[TBL] [Abstract][Full Text] [Related]
12. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
Cai J; Qiao B; Gao N; Lin N; He W
Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MINCR activates Wnt/β-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma.
Lyu Q; Jin L; Yang X; Zhang F
Pathol Res Pract; 2019 May; 215(5):924-930. PubMed ID: 30777615
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway.
Yu T; Liu K; Wu Y; Fan J; Chen J; Li C; Yang Q; Wang Z
Oncogene; 2014 Oct; 33(42):5017-27. PubMed ID: 24141785
[TBL] [Abstract][Full Text] [Related]
15. NCAPD2 promotes the malignant progression of oral squamous cell carcinoma via the Wnt/β-catenin pathway.
Ma P; Yu H; Zhu M; Liu L; Cheng L; Han Z; Jin W
Cell Cycle; 2024 Mar; 23(5):588-601. PubMed ID: 38743408
[TBL] [Abstract][Full Text] [Related]
16. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
[TBL] [Abstract][Full Text] [Related]
17. SNHG17/miR-384/ELF1 axis promotes cell growth by transcriptional regulation of CTNNB1 to activate Wnt/β-catenin pathway in oral squamous cell carcinoma.
Qiao C; Qiao T; Yang S; Liu L; Zheng M
Cancer Gene Ther; 2022 Jan; 29(1):122-132. PubMed ID: 33531646
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Nav1.5 inhibits cell proliferation, migration and invasion via Wnt/β-catenin signaling pathway in oral squamous cell carcinoma.
Xu X; Dai Y; Feng L; Zhang H; Hu Y; Xu L; Zhu X; Jiang Y
Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):527-535. PubMed ID: 32400862
[TBL] [Abstract][Full Text] [Related]
19. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
Chang XS; Zhu J; Yang T; Gao Y
Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
[TBL] [Abstract][Full Text] [Related]
20. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
Lin X; Ding JM; Zheng XZ; Chen JG
Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
